China Medicine Corp
OTC:CHME
China Medicine Corp
OTC:CHME
Price:
0.035
USD
Market Closed
Market Cap:
$974.4k
Income Statement
Earnings Waterfall
China Medicine Corp
China Medicine Corp
Income Statement
China Medicine Corp
China Medicine Corp
Currency: USD
| Dec-2005 | Mar-2006 | Jun-2006 | Sep-2006 | Dec-2006 | Mar-2007 | Jun-2007 | Sep-2007 | Dec-2007 | Mar-2008 | Jun-2008 | Sep-2008 | Dec-2008 | Mar-2009 | Jun-2009 | Sep-2009 | Dec-2009 | Mar-2010 | Jun-2010 | Sep-2010 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Revenue |
15
N/A
|
16
+7%
|
17
+7%
|
22
+29%
|
24
+8%
|
25
+5%
|
30
+17%
|
34
+17%
|
42
+22%
|
44
+5%
|
47
+8%
|
45
-4%
|
54
+18%
|
57
+6%
|
60
+6%
|
69
+14%
|
65
-6%
|
65
+1%
|
67
+3%
|
66
-2%
|
|
| Gross Profit | |||||||||||||||||||||
| Cost of Revenue |
(9)
|
(9)
|
(10)
|
(13)
|
(15)
|
(16)
|
(19)
|
(23)
|
(30)
|
(31)
|
(33)
|
(31)
|
(38)
|
(41)
|
(45)
|
(51)
|
(46)
|
(46)
|
(45)
|
(44)
|
|
| Gross Profit |
6
N/A
|
7
+7%
|
7
+1%
|
9
+33%
|
9
-1%
|
9
+4%
|
11
+14%
|
11
+7%
|
12
+9%
|
13
+5%
|
15
+14%
|
14
-4%
|
16
+10%
|
16
+3%
|
15
-4%
|
18
+17%
|
19
+6%
|
19
+2%
|
22
+13%
|
22
0%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(7)
|
(8)
|
(8)
|
(10)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(6)
|
(6)
|
(7)
|
|
| Research & Development |
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(3)
|
|
| Operating Income |
5
N/A
|
5
-8%
|
4
-20%
|
6
+50%
|
7
+22%
|
7
+2%
|
8
+15%
|
8
-5%
|
8
+5%
|
9
+6%
|
10
+17%
|
10
-3%
|
11
+8%
|
11
+3%
|
10
-11%
|
12
+22%
|
12
0%
|
12
-4%
|
14
+17%
|
12
-15%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(2)
|
(7)
|
(5)
|
(3)
|
(2)
|
|
| Non-Reccuring Items |
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
6
N/A
|
5
-13%
|
4
-20%
|
5
+20%
|
6
+26%
|
6
+8%
|
8
+17%
|
8
+5%
|
8
+6%
|
9
+6%
|
10
+18%
|
10
-3%
|
11
+8%
|
11
-4%
|
8
-23%
|
10
+25%
|
5
-51%
|
6
+25%
|
11
+74%
|
9
-12%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
|
| Income from Continuing Operations |
6
|
5
|
4
|
4
|
5
|
5
|
6
|
6
|
7
|
7
|
9
|
8
|
9
|
8
|
6
|
7
|
1
|
3
|
7
|
6
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
6
N/A
|
5
-16%
|
4
-22%
|
4
+8%
|
5
+20%
|
5
+10%
|
6
+17%
|
7
+6%
|
7
+6%
|
7
+6%
|
9
+18%
|
8
-3%
|
9
+9%
|
9
-7%
|
6
-29%
|
7
+21%
|
2
-77%
|
(3)
N/A
|
1
N/A
|
(0)
N/A
|
|
| EPS (Diluted) |
0.87
N/A
|
0.66
-24%
|
0.49
-26%
|
0.5
+2%
|
0.63
+26%
|
0.4
-37%
|
0.43
+7%
|
0.41
-5%
|
0.5
+22%
|
0.47
-6%
|
0.55
+17%
|
0.54
-2%
|
0.6
+11%
|
0.56
-7%
|
0.4
-29%
|
0.48
+20%
|
0.11
-77%
|
-0.16
N/A
|
0.02
N/A
|
0
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
